cookies-img
We use third-party cookies to provide support. By continuing to browse this website, you accept our privacy policy.
close-icon
Repare Therapeutics Inc
10 own
11 watching
Current Price
$3.8
$-0.12
(-3.06%)
arrow-icon
1 Week Returns
3 Months Returns
1 Year Returns

Get Started with as little as $1.00

Market Capitalization
Market Capitalization
211.36M
52-Week High
52-Week High
13.85000
52-Week Low
52-Week Low
2.98000
Average Volume
Average Volume
0.09M
Dividend Yield
Dividend Yield
--
P/E Ratio
P/E Ratio
--
iconMarket Capitalization211.36M
icon52-Week High13.85000
icon52-Week Low2.98000
iconAverage Volume0.09M
iconDividend Yield--
iconP/E Ratio--
What does the Repare Therapeutics Inc do?
N/A
Read More
How much money does Repare Therapeutics Inc make?
News & Events about Repare Therapeutics Inc.
Ticker Report
1 year ago
Repare Therapeutics (NASDAQ:RPTX Get Rating) was upgraded by Stifel Nicolaus from a hold rating to a buy rating in a note issued to investors on Friday, The Fly reports. The brokerage currently has a $16.00 price target on the stock, up from their previous price ...
Zolmax
1 year ago
Repare Therapeutics (NASDAQ:RPTX Get Rating) had its target price upped by equities researchers at HC Wainwright from $25.00 to $26.00 in a research report issued to clients and investors on Friday, The Fly reports. HC Wainwrights price objective points to a potential upside of 116.31% from the ...
Business Wire
1 year ago
Repare Therapeutics Inc. (Repare or the Company) (Nasdaq: RPTX), a leading clinical-stage precision oncology company, today presented initial data from its ongoing Phase 1/2 TRESR clinical trial evaluating camonsertib (RP-3500/RG6526, partnered with Roche), a potent and selective oral small...
Globe Newswire
1 year ago
NEW YORK, Feb. 14, 2023 (GLOBE NEWSWIRE) -- Pomerantz LLP is investigating claims on behalf of investors of Repare Therapeutics Inc. (Repare or the Company) (NASDAQ: RPTX). Such investors are advised to contact Robert S. Willoughby at newaction@pomlaw.com or 888-476-6529, ext. 7980. The ...
PR Newswire
1 year ago
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Repare Therapeutics Inc. - RPTX SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Repare Therapeutics Inc. - RPTX PR Newswire NEW YORK, Feb. 13, 2023 NEW YORK, Feb. 13, 2023...
Frequently Asked Questions
Frequently Asked Questions
What is Repare Therapeutics Inc share price today?
plus_minus_icon
Can Indians buy Repare Therapeutics Inc shares?
plus_minus_icon
How can I buy Repare Therapeutics Inc shares from India?
plus_minus_icon
Can Fractional shares of Repare Therapeutics Inc be purchased?
plus_minus_icon
What are the documents required to start investing in Repare Therapeutics Inc stocks?
plus_minus_icon
What is today’s traded volume of Repare Therapeutics Inc?
plus_minus_icon
What is today’s market capitalisation of Repare Therapeutics Inc?
plus_minus_icon
What is the 52-Week High and Low Range of Repare Therapeutics Inc?
plus_minus_icon
What percentage is Repare Therapeutics Inc down from its 52-Week High?
plus_minus_icon
What percentage is Repare Therapeutics Inc up from its 52-Week Low?
plus_minus_icon
Current Price
$3.8
$-0.12
(-3.06%)
arrow-icon
1 Week Returns
3 Months Returns
1 Year Returns

Get Started with as little as $1.00

Get Started with as little as $1.00